Concepedia

Mark Halvorsen

MH

8

Publications

204

Citations

8

H-Index

2003

Active since

Affiliations

Upsher-Smith Laboratories (United States)(Current)

Hebrew University of Jerusalem

Mark Halvorsen is an author at Upsher-Smith Laboratories (United States) specializing in pharmacotherapy, vaccination, and pediatrics.

Top concepts

Publications per year

2003–2015

8

Publications

8

Once‐daily <scp>USL</scp>255 as adjunctive treatment of partial‐onset seizures: Randomized phase <scp>III</scp> study

Steve Chung, Toufic Fakhoury, R. Edward Hogan et al. · Epilepsia · 2014 · 35 citations · Full text

Pharmacokinetics, pharmacodynamics, and safety of <scp>USL</scp>261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers

Lindy Bancke, Heather A. Dworak, Keith A. Rodvold et al. · Epilepsia · 2015 · 31 citations · Full text

Transdermal estradiol gel 0.1% for the treatment of vasomotor symptoms in postmenopausal women

Richard E. Hedrick, Ronald Ackerman, William Koltun et al. · Menopause The Journal of The North American Menopause Society · 2009 · 31 citations

Comparative steady‐state pharmacokinetic evaluation of immediate‐release topiramate and <scp>USL</scp>255, a once‐daily extended‐release topiramate formulation

Meir Bialer, Tawfeeq Shekh‐Ahmad, Tricia Braun et al. · Epilepsia · 2013 · 30 citations · Full text

Comparative pharmacokinetic analysis of USL255, a new once-daily extended-release formulation of topiramate

Lawrence J. Lambrecht, Tawfeeq Shekh‐Ahmad, W. Todd et al. · Epilepsia · 2011 · 23 citations

Rows per page

1–5 of 8